Stemline Therapeutics Reports First Quarter 2019 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T
6. SPY
7. CVS
8. UNH
9. TMUS
10. LMT

Go back to Stemline Therapeutics Reports First Quarter 2019 Financial Results

Stemline Therapeutics (STML) Misses Q1 EPS by 10c, Revenues Beat

May 10, 2019 6:36 AM EDT

Stemline Therapeutics (NASDAQ: STML) reported Q1 EPS of ($0.73), $0.10 worse than the analyst estimate of ($0.63). Revenue for the quarter came in at $5.05 million versus the consensus estimate of $2.36 million.

Since ELZONRIS became commercially available in January, we have been very pleased with the... More